Logo image of MAGN

MAGNERA CORP (MAGN) Stock Fundamental Analysis

USA - NYSE:MAGN - US55939A1079 - Common Stock

9.94 USD
-0.46 (-4.42%)
Last: 10/10/2025, 8:41:44 PM
9.94 USD
0 (0%)
After Hours: 10/10/2025, 8:41:44 PM
Fundamental Rating

3

MAGN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 10 industry peers in the Paper & Forest Products industry. MAGN has a bad profitability rating. Also its financial health evaluation is rather negative. MAGN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year MAGN has reported negative net income.
MAGN had a negative operating cash flow in the past year.
In multiple years MAGN reported negative net income over the last 5 years.
In multiple years MAGN reported negative operating cash flow during the last 5 years.
MAGN Yearly Net Income VS EBIT VS OCF VS FCFMAGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

1.2 Ratios

MAGN has a Return On Assets (-3.26%) which is comparable to the rest of the industry.
MAGN's Return On Equity of -11.87% is on the low side compared to the rest of the industry. MAGN is outperformed by 60.00% of its industry peers.
The Return On Invested Capital of MAGN (1.50%) is better than 70.00% of its industry peers.
MAGN had an Average Return On Invested Capital over the past 3 years of 1.29%. This is below the industry average of 5.72%.
The 3 year average ROIC (1.29%) for MAGN is below the current ROIC(1.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -3.26%
ROE -11.87%
ROIC 1.5%
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%
MAGN Yearly ROA, ROE, ROICMAGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

MAGN's Operating Margin of 2.48% is fine compared to the rest of the industry. MAGN outperforms 70.00% of its industry peers.
MAGN's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 10.55%, MAGN perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
MAGN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.48%
PM (TTM) N/A
GM 10.55%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%
MAGN Yearly Profit, Operating, Gross MarginsMAGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MAGN is destroying value.
MAGN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for MAGN has been reduced compared to 5 years ago.
Compared to 1 year ago, MAGN has a worse debt to assets ratio.
MAGN Yearly Shares OutstandingMAGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
MAGN Yearly Total Debt VS Total AssetsMAGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

MAGN has an Altman-Z score of 1.00. This is a bad value and indicates that MAGN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.00, MAGN is doing worse than 80.00% of the companies in the same industry.
MAGN has a Debt/Equity ratio of 1.76. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of MAGN (1.76) is worse than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF N/A
Altman-Z 1
ROIC/WACC0.21
WACC7.31%
MAGN Yearly LT Debt VS Equity VS FCFMAGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.54 indicates that MAGN has no problem at all paying its short term obligations.
MAGN has a Current ratio (2.54) which is comparable to the rest of the industry.
A Quick Ratio of 1.63 indicates that MAGN should not have too much problems paying its short term obligations.
MAGN has a better Quick ratio (1.63) than 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 1.63
MAGN Yearly Current Assets VS Current LiabilitesMAGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

MAGN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -93.18%.
The Revenue has decreased by -7.09% in the past year.
Measured over the past years, MAGN shows a quite strong growth in Revenue. The Revenue has been growing by 9.85% on average per year.
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-7.09%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%152.63%

3.2 Future

MAGN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.60% yearly.
Based on estimates for the next years, MAGN will show a very strong growth in Revenue. The Revenue will grow by 21.34% on average per year.
EPS Next Y-14%
EPS Next 2Y16.28%
EPS Next 3Y28.95%
EPS Next 5Y36.6%
Revenue Next Year120.68%
Revenue Next 2Y41.92%
Revenue Next 3Y28.37%
Revenue Next 5Y21.34%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MAGN Yearly Revenue VS EstimatesMAGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
MAGN Yearly EPS VS EstimatesMAGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15 20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MAGN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MAGN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAGN Price Earnings VS Forward Price EarningsMAGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

MAGN's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.06
MAGN Per share dataMAGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as MAGN's earnings are expected to grow with 28.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.28%
EPS Next 3Y28.95%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MAGN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAGNERA CORP

NYSE:MAGN (10/10/2025, 8:41:44 PM)

After market: 9.94 0 (0%)

9.94

-0.46 (-4.42%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)01-07 2026-01-07
Inst Owners101.93%
Inst Owner Change1.03%
Ins Owners0.54%
Ins Owner Change19.9%
Market Cap353.86M
Analysts45.71
Price Target14.28 (43.66%)
Short Float %10.36%
Short Ratio5.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.23%
Min Revenue beat(2)-4.4%
Max Revenue beat(2)-4.06%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 0.31
P/tB 1.82
EV/EBITDA 8.06
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.55
Fwd EYN/A
FCF(TTM)-2.39
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS75.76
BVpS31.77
TBVpS5.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.26%
ROE -11.87%
ROCE 1.9%
ROIC 1.5%
ROICexc 1.63%
ROICexgc 2.29%
OM 2.48%
PM (TTM) N/A
GM 10.55%
FCFM N/A
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.29%
ROIC(5y)2.28%
ROICexc(3y)1.4%
ROICexc(5y)2.53%
ROICexgc(3y)1.77%
ROICexgc(5y)3.33%
ROCE(3y)1.65%
ROCE(5y)2.9%
ROICexcg growth 3Y-33.98%
ROICexcg growth 5Y-5.57%
ROICexc growth 3Y-31.54%
ROICexc growth 5Y-3.54%
OM growth 3Y-34.91%
OM growth 5Y-7.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.6%
GM growth 5Y-9.06%
F-Score4
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF N/A
Debt/EBITDA 7.73
Cap/Depr 28.75%
Cap/Sales 2.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.54
Quick Ratio 1.63
Altman-Z 1
F-Score4
WACC7.31%
ROIC/WACC0.21
Cap/Depr(3y)52.93%
Cap/Depr(5y)52.63%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-14%
EPS Next 2Y16.28%
EPS Next 3Y28.95%
EPS Next 5Y36.6%
Revenue 1Y (TTM)-7.09%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%152.63%
Revenue Next Year120.68%
Revenue Next 2Y41.92%
Revenue Next 3Y28.37%
Revenue Next 5Y21.34%
EBIT growth 1Y117.08%
EBIT growth 3Y-25.3%
EBIT growth 5Y1.43%
EBIT Next Year515.25%
EBIT Next 3Y84.42%
EBIT Next 5Y60.13%
FCF growth 1Y-62.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-177.22%
OCF growth 3YN/A
OCF growth 5YN/A